Kenneth J Kelley insider trades: Halozyme Therapeutics (HALO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kenneth reports to the SEC
Open-market buys and sales
24 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 14, 2021 | HALO | ↓ Sell | 5,000 | $45.00 | $225K | Direct | Apr 14, 2021 (0d) |
| Mar 1, 2021 | HALO | ↓ Sell | 5,000 | $45.34 | $227K | Direct | Mar 1, 2021 (0d) |
| Feb 1, 2021 | HALO | ↓ Sell | 5,000 | $48.12 | $241K | Direct | Feb 1, 2021 (0d) |
| Jan 4, 2021 | HALO | ↓ Sell | 5,000 | $42.91 | $215K | Direct | Jan 4, 2021 (0d) |
| Dec 7, 2020 | HALO | ↓ Sell | 35,086 | $41.00 | $1.4M | Direct | Dec 7, 2020 (0d) |
| Dec 2, 2020 | HALO | ↓ Sell | 31,792 | $41.00 | $1.3M | Direct | Dec 2, 2020 (0d) |
| Nov 27, 2020 | HALO | ↓ Sell | 19,671 | $41.37 | $814K | Direct | Nov 27, 2020 (0d) |
| Mar 19, 2020 | HALO | ↑ Buy | 52,629 | $14.23 | $749K | Direct | Mar 19, 2020 (0d) |
| Jun 18, 2015 | HALO | ↓ Sell | 20,000 | $21.00 | $420K | Direct | Jun 22, 2015 (4d) |
| Mar 5, 2015 | HALO | ↓ Sell | 40,000 | $15.33 | $613K | Direct | Mar 9, 2015 (4d) |
| Aug 27, 2012 | HALO | ↑ Buy | 20,000 | $5.70 | $114K | Direct | Aug 28, 2012 (1d) |
| May 14, 2012 | HALO | ↑ Buy | 20,000 | $7.49 | $150K | Direct | May 16, 2012 (2d) |
| May 25, 2007 | HALO | ↓ Sell | 22,500 | $10.26 | $231K | Direct | May 25, 2007 (0d) |
| May 18, 2007 | HALO | ↓ Sell | 15,000 | $10.55 | $158K | Direct | May 22, 2007 (4d) |
| May 7, 2007 | HTI | ↓ Sell | 12,500 | $10.40 | $130K | Direct | May 9, 2007 (2d) |
| Apr 30, 2007 | HTI | ↓ Sell | 25,000 | $10.32 | $258K | Direct | May 1, 2007 (1d) |
| Apr 23, 2007 | HTI | ↓ Sell | 25,000 | $8.84 | $221K | Direct | Apr 24, 2007 (1d) |
| Apr 16, 2007 | HTI | ↓ Sell | 25,000 | $9.07 | $227K | Direct | Apr 17, 2007 (1d) |
| Apr 9, 2007 | HTI | ↓ Sell | 25,000 | $8.46 | $211K | Direct | Apr 10, 2007 (1d) |
| Apr 2, 2007 | HTI | ↓ Sell | 25,000 | $8.05 | $201K | Direct | Apr 4, 2007 (2d) |
| Mar 27, 2007 | HTI | ↓ Sell | 24,500 | $8.37 | $205K | Direct | Mar 28, 2007 (1d) |
| Mar 27, 2007 | HTI | ↓ Sell | 500 | $8.38 | $4K | Direct | Mar 28, 2007 (1d) |
| Mar 19, 2007 | HTI | ↓ Sell | 25,000 | $8.70 | $218K | Direct | Mar 21, 2007 (2d) |
| Mar 14, 2007 | HTI | ↓ Sell10b5-1 | 25,000 | $7.96 | $199K | Direct | Mar 16, 2007 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other HALO insiders
Open-market trades in the last 12 months
About Kenneth J Kelley's insider trades
Kenneth J Kelley is a director at Halozyme Therapeutics (HALO). Since Mar 14, 2007, Kenneth has reported 3 open-market purchases worth $1.0M and 21 sales worth $7.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (3% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (15 filings), option exercises (12 filings), inherited shares (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HALO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.